The DiSCOVER Trial: Part 1

The DiSCOVER Trial: Part 1

Part 1 of a two-part interview featuring Chris Schelling, CEO and Founder of Acer Therapeutics, and Dr. Adrian Quartel, Chief Medical Officer of Acer Therapeutics. In this episode, Chris joins to discuss the history of Edsivo, or celiprolol, and the DiSCOVER trial, a clinical trial for Edsivo enrolling people with VEDS  (Vascular Ehlers-Danlos Syndrome) in the United States. 

Learn more about the DiSCOVER Trial at 

Find more information about VEDS, including support groups and medical webinars, at

If you would like to share your story with VEDS on this podcast, visit

Links mentioned in the episode:

DiSCOVER Trial: 

VEDS Camp, hosted by the Ehlers-Danlos Society in partnership with The VEDS Movement

The Marfan Foundation Conference:

The Marfan Foundation Walk for Victory:

Team VEDS- Pacific Northwest Walk for Victory


You can support this podcast by subscribing to my Patreon at 

Thank you to all my patrons for supporting the show, and extra thanks to my top-tier Connected Patrons:

Jon Holtom
Kacey Keegan
Ashton Tanner


The views, information and opinions in the podcast are solely those of the individuals involved and the information presented does not constitute medical or other professional advice or services. Any opinions I express in this podcast are my own, and not of my employer. 

Comments are closed.